Filing Details

Accession Number:
0001209191-20-049778
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-08 18:14:10
Reporting Period:
2020-09-03
Accepted Time:
2020-09-08 18:14:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1304492 Anterix Inc. ATEX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
937846 E Morgan Obrien 3 Garret Mountain Plaza
Suite 401
Woodland Park NJ 07424
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-03 26,009 $0.00 108,600 No 4 A Direct
Common Stock Disposition 2020-09-04 9,715 $42.30 98,885 No 4 S Direct
Common Stock Disposition 2020-09-08 4,635 $40.18 94,250 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2020-09-03 26,464 $0.00 26,464 $46.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,464 2020-09-03 2025-08-29 No 4 A Direct
Footnotes
  1. On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.
  2. Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020.
  3. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.00 to $42.63. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $39.92 to $40.85. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  5. On February 28, 2020, the Reporting Person was granted a performance-based stock option, which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the stock option.